Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Homonymous Visual Loss With Digital Therapeutics, VIVID Brain, Visual Perceptual Learning Device (HOGWAND Trial) : Multi Center, Randomized, Single-blind (Evaluator), Superiority Prove, Prospective Confirmatory Trial

NCT05525949 is registered in ClinicalTrials.gov with Nunaps Inc as lead sponsor.

NCT NCT05525949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05525949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Homonymous Visual Loss With Digital Therapeutics, VIVID Brain, Visual Perceptual Learning Device (HOGWAND Trial) : Multi Center, Randomized, Single-blind (Evaluator), Superiority Prove, Prospective Confirmatory Trial
Lead sponsor
Nunaps Inc
Phase
Not applicable
Overall status
Completed
Start date
October 19, 2022
Completion date
November 8, 2023
Enrollment
93 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hemianopsia, homonymous, visual fields hemianopsia